Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phthalazines with angiogenesis inhibiting activity

Phthalazines with angiogenesis inhibiting activity

US Patent 6710047 · Granted Mar 23, 2004

Estimated economic value: $14,306,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Fusion protein composition(s) comprising masked type i interferons (IFNA and IFN2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2023
Formulated and/or co-formulated liposome compositions containing TFGB antagonist2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2023
Formulated and/or co-formulated liposome compositions containing toll-like recep2023
Formulated and/or co-formulated liposome compositions containing toll-like recep2023
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFN2021
Imidazopyrrolidine derivatives and their use in the treatment of disease2018